Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Remimazolam tosylate obtains first approval in China

Dec. 30, 2019

GABRA5 positive allosteric modulators designed at Roche

Dec. 30, 2019

Muscarinic M1 receptor PAMs reported in Vanderbilt University patent

Dec. 30, 2019

Praxis Precision Medicines patents voltage-gated sodium channel blockers

Dec. 30, 2019

Janssen presents results from phase II trials of JNJ-42165279

Dec. 30, 2019

Baergic Bio enters agreements with AstraZeneca and Cincinnati Children's Hospital for AZD-7325

Dec. 27, 2019

RAN protein is ALS target

Dec. 27, 2019

Novel transgenic mouse model of memory impairment

Dec. 27, 2019

Ubrogepant approved by the FDA for migraine

Dec. 24, 2019

Lumateperone approved in the U.S. for schizophrenia

Dec. 24, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...